Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 9, 2014, Pages 1603-1610

  Sirich, Tammy L ^a   Plummer, Natalie S ^a   Gardner, Christopher D ^a   Hostetter, Thomas H ^b   Meyer, Timothy W ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CRESOL; INDICAN; NITROGEN; P CRESOL SULFATE; PHOSPHATE; PREALBUMIN; UNCLASSIFIED DRUG; 4-CRESOL SULFATE; SULFATE;

ADULT; ARTICLE; CLINICAL ARTICLE; DIETARY FIBER; FEMALE; HEMODIALYSIS; HUMAN; LIQUID CHROMATOGRAPHY; MALE; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TANDEM MASS SPECTROMETRY; ADMINISTRATION AND DOSAGE; BLOOD; COLON; CONTROLLED STUDY; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY; SINGLE BLIND PROCEDURE;

COLON; CRESOLS; DIETARY FIBER; FEMALE; HUMANS; INDICAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; SINGLE-BLIND METHOD; SULFURIC ACID ESTERS;

EID: 84920841597     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00490114     Document Type: Article

References (45)

1. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G: Metabolomics analysis reveals large effects of gut microflora on mammalian bloodmetabolites. ProcNatl Acad Sci U S A 106: 3698–3703, 2009.
2. Schepers E, Glorieux G, Vanholder R: The gut: The forgotten organ in uremia? Blood Purif 29: 130–136, 2010.
3. Evenepoel P, Meijers BK, Bammens BR, Verbeke K: Uremic toxins originating from colonic microbial metabolism. Kidney Int Suppl 114: S12–S19, 2009.
4. Meyer TW, Hostetter TH: Uremic solutes from colon microbes. Kidney Int 81: 949–954, 2012.
5. Aronov PA, Luo FJ, Plummer NS, Quan Z, Holmes S, Hostetter TH, Meyer TW: Colonic contribution to uremic solutes. J AmSoc Nephrol 22: 1769–1776, 2011.
6. Niwa T: Indoxyl sulfate is a nephro-vascular toxin. J Ren Nutr 20 [Suppl]: S2–S6, 2010.
7. Meijers BK, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P: Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 73: 1174–1180, 2008.
8. Liabeuf S, Barreto DV, Barreto FC, Meert N, Glorieux G, Schepers E, Temmar M, Choukroun G, Vanholder R, Massy ZA; European Uraemic Toxin Work Group (EUTox): Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 25: 1183–1191, 2010.
9. Meijers BK, Van Kerckhoven S, Verbeke K, Dehaen W, Vanrenterghem Y, Hoylaerts MF, Evenepoel P: The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 54: 891–901, 2009.
10. Schepers E, Meert N, Glorieux G, Goeman J, Van der Eycken J, Vanholder R: P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant 22: 592–596, 2007.
11. Lesaffer G, De Smet R, Lameire N, Dhondt A, Duym P, Vanholder R: Intradialytic removal of protein-bound uraemic toxins: Role of solute characteristics and of dialyser membrane. Nephrol Dial Transplant 15: 50–57, 2000.
12. Meijers BK, De Preter V, Verbeke K, Vanrenterghem Y, Evenepoel P: p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrol Dial Transplant 25: 219–224, 2010.
13. Evenepoel P, Meijers BK: Dietary fiber and protein: Nutritional therapy in chronic kidney disease and beyond. Kidney Int 81: 227–229, 2012.
14. Cummings JH, Stephen AM: Carbohydrate terminology and classification. Eur J Clin Nutr 61[Suppl 1]: S5–S18, 2007.
15. Burkitt DP, Walker AR, Painter NS: Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease. Lancet 2: 1408–1412, 1972.
16. Flint HJ: The impact of nutrition on the human microbiome. Nutr Rev 70[Suppl 1]: S10–S13, 2012.
17. Kalmokoff M, Zwicker B, O’Hara M, Matias F, Green J, Shastri P, Green-Johnson J, Brooks SP: Temporal change in the gut community of rats fed high amylose cornstarch is driven by endogenous urea rather than strictly on carbohydrate availability. J Appl Microbiol 114: 1516–1528, 2013.
18. Sirich TL, Aronov PA, Plummer NS, Hostetter TH, Meyer TW: Numerous protein-bound solutes are cleared by the kidney with high efficiency. Kidney Int 84: 585–590, 2013.
19. Raimann JG, Thijssen S, Ramos R, Levin NW: More frequent hemodialysis: What do we know? Where do we stand? Contrib Nephrol 171: 10–16, 2011.
20. Canaud B, Bowry SK: Emerging clinical evidence on online hemodiafiltration: Does volume of ultrafiltration matter? Blood Purif 35: 55–62, 2013.
21. Dethlefsen L, McFall-Ngai M, Relman DA: An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449: 811–818, 2007.
22. Tremaroli V, Ba¨ckhed F: Functional interactions between the gut microbiota and host metabolism. Nature 489: 242–249, 2012.
23. Ramezani A, Raj DS: The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol 25: 657–670, 2014.
24. Rampton DS, Cohen SL, Crammond VD, Gibbons J, Lilburn MF, Rabet JY, Vince AJ, Wager JD, Wrong OM: Treatment of chronic renal failure with dietary fiber. Clin Nephrol 21: 159–163, 1984.
25. Younes H, Alphonse JC, Behr SR, Demigne´ C, Rémésy C: Role of fermentable carbohydrate supplementswith a low-protein diet in the course of chronic renal failure: Experimental bases. Am J Kidney Dis 33: 633–646, 1999.
26. Bliss DZ, Stein TP, Schleifer CR, Settle RG: Supplementation with gum arabic fiber increases fecal nitrogen excretion and lowers serum urea nitrogen concentration in chronic renal failure patients consuming a low-protein diet. AmJ ClinNutr 63: 392–398, 1996.
27. Birkett A, Muir J, Phillips J, Jones G, O’Dea K: Resistant starch lowers fecal concentrations of ammonia and phenols in humans. Am J Clin Nutr 63: 766–772, 1996.
28. Grabitske HA, Slavin JL: Gastrointestinal effects of low-digestible carbohydrates. Crit Rev Food Sci Nutr 49: 327–360, 2009.
29. Smith EA, Macfarlane GT: Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine. Microb Ecol 33: 180–188, 1997.
30. Sonnenburg ED, Zheng H, Joglekar P, Higginbottom SK, Firbank SJ, Bolam DN, Sonnenburg JL: Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell 141: 1241–1252, 2010.
31. Poesen R, Viaene L, Verbeke K, Claes K, Bammens B, Sprangers B, Naesens M, Vanrenterghem Y, Kuypers D, Evenepoel P, Meijers B: Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD. Clin J Am Soc Nephrol 8: 1508–1514, 2013.
32. Patel KP, Luo FJ, Plummer NS, Hostetter TH, Meyer TW: The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores. Clin J Am Soc Nephrol 7: 982–988, 2012.
33. Schmidt S, Gonzalez D, Derendorf H: Significance of protein binding in pharmacokinetics and pharmacodynamics. J Pharm Sci 99: 1107–1122, 2010.
34. von Winckelmann SL, Spriet I, Willems L: Therapeutic drug monitoring of phenytoin in critically ill patients. Pharmacotherapy 28: 1391–1400, 2008.
35. Walther JL, Bartlett DW, Chew W, Robertson CR, Hostetter TH, Meyer TW: Downloadable computer models for renal replacement therapy. Kidney Int 69: 1056–1063, 2006.
36. Meyer TW, Leeper EC, Bartlett DW, Depner TA, Lit YZ, Robertson CR, Hostetter TH: Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of proteinbound solutes. J Am Soc Nephrol 15: 1927–1935, 2004.
37. Gulyassy PF, Depner TA: Impaired binding of drugs and endogenous ligands in renal diseases. Am J Kidney Dis 2: 578–601, 1983.
38. Klammt S, Wojak HJ, Mitzner A, Koball S, Rychly J, Reisinger EC, Mitzner S: Albumin-binding capacity (ABiC) is reduced in patients with chronic kidney disease along with an accumulation of protein-bound uraemic toxins. Nephrol Dial Transplant 27: 2377–2383, 2012.
39. Vaziri ND: CKD impairs barrier function and alters microbial flora of the intestine: A major link to inflammation and uremic toxicity. Curr Opin Nephrol Hypertens 21: 587–592, 2012.
40. Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, De Santis TZ, Ni Z, Nguyen TH, Andersen GL: Chronic kidney disease alters intestinal microbial flora. Kidney Int 83: 308–315, 2013.
41. Schulman G, Vanholder R, Niwa T: AST-120 for themanagement of progression of chronic kidney disease. Int J Nephrol Renovasc Dis 7: 49–56, 2014.
42. Evenepoel P, Bammens B, Verbeke K, Vanrenterghem Y: Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: A pilot study. Kidney Int 70: 192–198, 2006.
43. Mabuchi H, Nakahashi H: Underestimation of serumalbumin by the bromcresol purplemethod and amajor endogenous ligand in uremia. Clin Chim Acta 167: 89–96, 1987.
44. Krishnamurthy VM, Wei G, Baird BC, Murtaugh M, Chonchol MB, Raphael KL, Greene T, Beddhu S: High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int 81: 300–306, 2012.
45. Kalantar-Zadeh K, Kopple JD, Deepak S, Block D, Block G: Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr 12: 17–31, 2002.